Screening for depression among chronically ill patients in community pharmacy settings: a pilot study in Bulgaria
Depression leads to a significant economic and financial burden, which determines the need for implementation of screening programs involving community pharmacists. The aim of this study was to screen patients with chronic conditions for depressive symptoms and to assess their current quality of lif...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Taylor & Francis Group
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/5b625542dbc642248f5e5db4be0adff9 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Depression leads to a significant economic and financial burden, which determines the need for implementation of screening programs involving community pharmacists. The aim of this study was to screen patients with chronic conditions for depressive symptoms and to assess their current quality of life at community pharmacies in Sofia Province, Bulgaria. A pilot prospective anonymous survey among patients with chronic diseases was conducted. Questionnaires were used: Patient Health Questionnaire-9 (PHQ-9), EQ-5D-5L and a specially designed questions list. The data were analyzed statistically using MedCalc software version 16.4.1. A total of 119 chronically ill patients were screened for depression by community pharmacists for the period March 2020–August 2020 during and after the first wave of the COVID-19 pandemic. Women (59.7%) and patients over 60 years of age (> 50%) predominated. Most patients had only one disease (47.2%), with the most common diseases being cardiovascular, followed by other endocrine and metabolic diseases. Of the respondents, 64.9% showed depressive symptoms, of which 50.9% were mild and 14% severe. The median pharmacotherapy cost was higher for patients with depression compared to patients who do not show depressive symptoms: BGN 28.50 compared to BGN 14.77. The obtained results suggest that the implementation of an early depression screening service in the community pharmacy settings would provide easy and timely access of patients to adequate mental care. The service would lead to improved quality of pharmaceutical care in Bulgaria and increased range of services that pharmacists offer in community pharmacy practice. |
|---|